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Abstract
Objective: To consider the problem of the calculation of number needed to treat (NNT) derived
from risk difference, odds ratio, and raw pooled events shown to give different results using data
from a review of nursing interventions for smoking cessation.
Discussion: A review of nursing interventions for smoking cessation from the Cochrane Library
provided different values for NNT depending on how NNTs were calculated. The Cochrane
review was evaluated for clinical heterogeneity using L'Abbé plot and subsequent analysis by
secondary and primary care settings.
Three studies in primary care had low (4%) baseline quit rates, and nursing interventions were
without effect. Seven trials in hospital settings with patients after cardiac surgery, or heart attack,
or even with cancer, had high baseline quit rates (25%). Nursing intervention to stop smoking in
the hospital setting was effective, with an NNT of 14 (95% confidence interval 9 to 26). The
assumptions involved in using risk difference and odds ratio scales for calculating NNTs are
discussed.
Summary:  Clinical common sense and concentration on raw data helps to detect clinical
heterogeneity. Once robust statistical tests have told us that an intervention works, we then need
to know how well it works. The number needed to treat or harm is just one way of showing that,
and when used sensibly can be a useful tool.
Background
Cates [1] concentrates on Simpson's paradox, which re-
lates to problems that can arise when there is an imbal-
ance between treatment and placebo arms in controlled
trials. This "paradox" is hardly new, having first been dis-
cussed by E.H. Simpson 50 years ago [2], and is now a sta-
ple of any undergraduate statistics course. Cates further
contends that NNTs should be calculated from weighted
risk differences (or odds ratios) rather than pooled raw
events, although this is relevant to Simpson's paradox
only if inappropriate statistical methods are being used in
inappropriate circumstances.
It all comes down to the old problem of meta-analysis, of
whether you are comparing apples with something else,
and how you count the apples when you've got them.
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The problem
All of this is based on a numerical analysis of a Cochrane
review of nursing interventions for smoking cessation [3].
The pooled raw data show that fewer people (14.3%) stop
smoking with a nursing intervention than with control
(15.6%): that is, the intervention does not work. Cates
wants us to believe that the "real" answer is different, and
that 3.7% more patients stop smoking with the interven-
tion than with control.
Clinical heterogeneity
This is, indeed, a paradox. But complicated statistical ar-
guments may not be the best way of dealing with it. When
faced with something that looks wrong, the first rule is to
look at the raw data. In this case a simple graphical repre-
sentation [4] of what happened in each trial helps.
Figure 1 shows a plot of the percentage of quitters for in-
tervention (Y-axis) and control (X-axis) for individual tri-
als. There is a huge variation, from about 2% to 60-70%
in each case. Since stopping smoking is universally judged
to be very difficult for most people, trials showing quit
rates of up to 55% without any intervention need a sec-
ond look. When examining the individual trials we find
that three (light blue) were done in primary care popula-
tions with no particular desire to stop smoking. We find
that seven trials (dark blue) were done in a hospital set-
ting, and included patients who had heart attacks, cardiac
surgery, or even had cancer. It is not surprising that their
attitude to stopping smoking was somewhat different.
L'Abbé plots using raw data will almost always show up
clinical heterogeneity, whereas Forrest plots, in which
data have been manipulated to create statistical outputs
like odds ratios or risk differences, will not.
Of course there are many other sources of clinical hetero-
geneity in these ten trials, apart from populations tested.
It was unlikely, for instance, that any two interventions
were the same, and we know that criteria for cessation
were different even within studies. Moreover, the problem
of trial imbalance comes from combining different inter-
ventions as if they were a single intervention [5,6].
The "real" results
If we believe that patients after coronary artery bypass, for
instance, are different in their motivation to stop smoking
from unselected general practice patients smoking at least
one cigarette per day, and analyse them separately, a more
sensible picture emerges (Table 1).
In hospital patients there was a significant relative benefit
from nursing interventions (using both random and fixed
effects models), with 7% more quitting smoking, and gen-
erating an NNT of 14. That is, for every 14 patients given
a nursing intervention, one more will quit smoking than
would have done without the nursing intervention. Many
will see this as a useful result, especially as these patients
need advice about other aspects of their lifestyle, like diet
and exercise.
In unselected primary care patients there was no benefit
from nursing interventions (using both random and fixed
effects models). Two of these three trials were unbalanced,
but even choosing the most effective of three interven-
tions in each to lose the imbalance would not affect the re-
sult. Nursing interventions in unselected primary care
patients are probably not effective.
These are the real results, and they are quite clear, despite
some misgivings about the trials.
Discussion
Different methods of calculating NNTs, using pooled raw
event rates, or from odds ratios, relative risk, or risk differ-
ence, will generally give much the same answer when
pooling information where the same outcome is meas-
ured over the same time for the same intervention in sim-
ilar patients, when the effect is large and where there is a
sufficiency of information. Variation in event rates may
just be a product of size [7], but when large variations exist
Figure 1
L'Abbé plot of nursing interventions versus control for
smoking cessation at longest follow up. Dark blue symbols
indicate studies in a hospital setting and light blue symbols
those in a primary care setting.BMC Medical Research Methodology 2002, 2 http://www.biomedcentral.com/1471-2288/2/2
Page 3 of 4
(page number not for citation purposes)
the presence of clinical heterogeneity should first be
sought.
Unfortunately much of the discussion on statistical tech-
niques put forward in Cates' article is confused and mis-
leading. Other authors have discussed these issues
cogently and coherently and interested readers are re-
ferred to these articles [8–12]. We will, however, comment
on one particular point which recurs throughout the arti-
cle, on the validity of pooling data, since this is funda-
mental to meta-analysis.
Any technique for combining data from a series of studies
or trials of a particular treatment or intervention must be
based on a set of assumptions about the nature of any pos-
itive or negative effect that results. These assumptions are
discussed below.
1 In the risk difference scale, the traditional assumption is
that the event rates are fixed in each of the control (control
event rate or CER) and treatment groups (experimental
event rate or EER). Any variation in the observed event
rates is then attributed to random chance. If the trials be-
ing combined are truly clinically homogeneous and have
been designed properly (for example, with balanced
arms), which is the situation that will commonly pertain,
then in this (and only in this) case it is appropriate to pool
raw data to obtain combined measures such as NNTs.
More recently the "random effects" model [10] has been
suggested to allow calculation of summary measures
when the degree of "statistical" heterogeneity is greater
than that occurring by random chance. This technique is
based on what Thompson & Pocock [11] have described
as "the peculiar premise that the trials done are represent-
ative of some hypothetical population of trials, and on the
unrealistic assumption that the heterogeneity between
studies can be represented by a single variance". We agree
with other authors [11,12] who contend that where con-
siderable heterogeneity is observed it is more useful to in-
vestigate what may have caused those differences (such as
the underlying differences between the inhospital and pri-
mary care patients in the nursing intervention study) than
to attempt to overcome them by statistical methods of un-
proven validity.
2 The assumptions underlying the odds ratio scale are very
different. Here we assume that the ratio of the odds of ob-
serving an effect (e.g. smoking cessation) in the treatment
group to the odds of observing that effect in the control
group are constant between trials. This scale is appropriate
where it can be demonstrated that whilst the underlying
event rates in both the control and treatment arms of the
trial may vary, the relative odds of those in whom we ob-
serve a particular effect remains fixed.
Techniques for combining odds ratios from several stud-
ies were developed primarily for case control studies (par-
ticularly cancer trials) to overcome problems due to
possible confounding factors (such as age) by stratifying
the data into internally homogeneous strata, then testing
the hypothesis that the odds ratio remains constant across
the strata. The odds ratio has been proposed as an appro-
priate technique for meta-analysis since it allows combi-
nation of the results from trials with widely differing
control event rates, but it is clearly a matter of some con-
tention whether such trials can be considered to be clini-
cally homogeneous. In particular, it seems to us to be very
unwise to use a summary odds ratio to calculate an NNT
value (even if the associated CER is quoted) since the NNT
is, by definition, dependent on the assumption of a fixed
underlying control event rate, whilst the odds ratio, also
by definition, is not. Any such NNT would therefore be of
very questionable value.
Table 1: Results for nursing interventions versus control analysed by hospital and primary care setting
Number quitting/total Percent quitting (95% CI)
Setting Number of studies Intervention Control Intervention Control Relative benefit
(95% CI)
NNT
(95% CI)
Hospital 7 435/1367 318/1295 32 (30 to 34) 25 (23 to 27) 1.3 (1.1 to 1.6) 14 (9 to 26)
Primary care 3 111/2453 41/1006 4.5 (3.7 to 5.3) 4.1 (2.9 to 5.3) 0.8 (0.3 to 2.6) 222 (52 to -98)
Combined 10 546/3820 359/2301 14 (12 to 16) 16 (14 to 18) 1.2 (0.9 to 1.6) -76 (184 to -32)BMC Medical Research Methodology 2002, 2 http://www.biomedcentral.com/1471-2288/2/2
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Our practice (as reflected in the two articles published in
Bandolier that Cates comments on; [14], [15]) of pooling
raw events to calculate an NNT has always been predicat-
ed on having clinically homogeneous trials in the first
place, and when outcomes, interventions and duration
are similar. Only then is an NNT useful, and only then will
an NNT calculated in this way be correct.
Conclusions
The lesson is that systematic reviews and meta-analyses
have to be done to high quality. Quality comes in differ-
ent guises, which might include gross imbalance between
the size of groups. What is needed is some clinical com-
mon sense and concentration on raw data. Yes, we need
robust statistical tests to tell us that an intervention works,
but we need also to know how well an intervention works.
The number needed to treat or harm is just one way of
showing how well an intervention works, and when used
sensibly can be a useful tool. Among GPs in Essex it was
the tool they felt most confident about using [13].
If we have only apples, then counting them should not be
a problem.
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